{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:13:10Z","timestamp":1793866390558,"version":"4.6.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.rdc.2013.10.003","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T23:11:15Z","timestamp":1385075475000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"title":["Cardiac Manifestations of Systemic Lupus Erythematosus"],"prefix":"10.1016","volume":"40","author":[{"given":"Jonathan J.","family":"Miner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred H.J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2013.10.003_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198307283090403","article-title":"Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block","volume":"309","author":"Scott","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.autrev.2004.11.003","article-title":"Transient autoimmunity related to maternal autoantibodies: neonatal lupus","volume":"4","author":"Lee","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2013.10.003_bib3","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","article-title":"Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus","volume":"42","author":"Saleeb","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.003_bib4","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rdc.2013.10.003_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2005.11.115","article-title":"Congenital complete heart block and maternal connective tissue disease","volume":"112","author":"Jayaprasad","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.rdc.2013.10.003_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11926-007-0003-4","article-title":"Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus","volume":"9","author":"Friedman","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2013.10.003_bib7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.20130","article-title":"Prolongation of the corrected QT interval in adult patients with anti-Ro\/SSA\u2013 positive connective tissue diseases","volume":"50","author":"Lazzerini","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.003_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/acr.20470","article-title":"Prolonged corrected QT interval in anti-Ro\/SSA\u2013positive adults with systemic lupus erythematosus","volume":"63","author":"Bourr\u00e9-Tessier","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2013.10.003_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.amjcard.2007.04.048","article-title":"Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro\/SSA and connective tissue disease","volume":"100","author":"Lazzerini","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rdc.2013.10.003_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/0891693031000067340","article-title":"Neonatal lupus: review of proposed pathogenesis and clinical data from the US-based Research Registry for Neonatal Lupus","volume":"36","author":"Buyon","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.rdc.2013.10.003_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJM198501103120206","article-title":"Maternal connective tissue disease and congenital heart block","volume":"312","author":"Litsey","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib12","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.003_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/1529-0131(200102)44:2<487::AID-ANR70>3.0.CO;2-D","article-title":"The rate of recurrence of isolated congenital heart block: a population-based study","volume":"44","author":"Julkunen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.003_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/art.1780400223","article-title":"Monozygotic twins discordant for congenital complete heart block","volume":"40","author":"Cooley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.003_bib15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.003_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-3083.2010.02440.x","article-title":"The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro\u200a\/\u200aSSA antibodies: a review","volume":"72","author":"Hutter","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.rdc.2013.10.003_bib17","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0022-3476(88)80581-X","article-title":"Postnatal progression from second- to third-degree heart block in neonatal lupus syndrome","volume":"113","author":"Geggel","year":"1988","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2013.10.003_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody\u2013associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.003_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4065\/74.3.275","article-title":"Cardiac involvement in systemic lupus erythematosus","volume":"74","author":"Moder","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rdc.2013.10.003_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM198809293191302","article-title":"Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus","volume":"319","author":"Galve","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.63.3.448","article-title":"Rapid development of constrictive pericarditis in a patient with systemic lupus erythematosus","volume":"63","author":"Starkey","year":"1973","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2013.10.003_bib22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.1780210815","article-title":"Constrictive pericarditis in systemic lupus erythematosus. Demonstration of immunoglobulins in the pericardium","volume":"21","author":"Jacobson","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.003_bib23","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.amjcard.2003.08.036","article-title":"Clinical and echocardiographic characteristics of hemodynamically significant pericardial effusions in patients with systemic lupus erythematosus","volume":"92","author":"Cauduro","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rdc.2013.10.003_bib24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0961203308100659","article-title":"The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review","volume":"18","author":"Rosenbaum","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2013.10.003_bib25","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/art.1780351115","article-title":"The spectrum of pericardial tamponade in systemic lupus erythematosus. Report of ten patients","volume":"35","author":"Kahl","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.003_bib26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/hrt.51.4.452","article-title":"Systemic lupus erythematosus presenting with cardiac tamponade","volume":"51","author":"Carroll","year":"1984","journal-title":"Br Heart J"},{"key":"10.1016\/j.rdc.2013.10.003_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006927","article-title":"Cardiac tamponade as the first manifestation of systemic lupus erythematosus in children","author":"Arabi","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.rdc.2013.10.003_bib28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/icb.2011.108","article-title":"Pathogenicity and proteomic signatures of autoantibodies to Ro and La","volume":"90","author":"Lindop","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.rdc.2013.10.003_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archinte.1980.00330130114028","article-title":"Immune complexes in the pericardial fluid in systemic lupus erythematosus","volume":"140","author":"Quismorio","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib30","first-page":"1980","article-title":"Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians","volume":"25","author":"Suarez-Almazor","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.003_bib31","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.108.844753","article-title":"Controversial issues in the management of pericardial diseases","volume":"121","author":"Imazio","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.003_bib32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/rheumatology\/kem371","article-title":"Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort","volume":"47","author":"Apte","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2013.10.003_bib33","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0002-8703(85)90023-7","article-title":"Cardiovascular manifestations of systemic lupus erythematosus","volume":"110","author":"Doherty","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.rdc.2013.10.003_bib34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jcp.2009.064311","article-title":"Cardiac pathology of systemic lupus erythematosus","volume":"62","author":"Jain","year":"2009","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.rdc.2013.10.003_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10554-006-9161-0","article-title":"Utility of cardiac MRI for diagnosis and post-treatment follow-up of lupus myocarditis","volume":"23","author":"Saremi","year":"2007","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.rdc.2013.10.003_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0961203312462265","article-title":"The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis","volume":"22","author":"Mavrogeni","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2013.10.003_bib37","first-page":"593","article-title":"Endomyocardial biopsy in patients with systemic lupus erythematosus","volume":"15","author":"Fairfax","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.003_bib38","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.4161\/cc.7.12.6162","article-title":"New roles for the major human 3\u2032- 5\u2032 exonuclease TREX1 in human disease","volume":"7","author":"Kavanagh","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.rdc.2013.10.003_bib39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.rdc.2013.10.003_bib40","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1128\/MCB.24.15.6719-6727.2004","article-title":"Gene-targeted mice lacking the Trex1 (DNase III) 3\u2032\u21925\u2032 DNA exonuclease develop inflammatory myocarditis","volume":"24","author":"Morita","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.rdc.2013.10.003_bib41","first-page":"87","article-title":"Mortality in systemic lupus erythematosus: the bimodal pattern revisited","volume":"55","author":"Rubin","year":"1985","journal-title":"QJM"},{"key":"10.1016\/j.rdc.2013.10.003_bib42","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1177\/0961203312462757","article-title":"Evidence for risk of cardiomyopathy with hydroxychloroquine","volume":"21","author":"Sumpter","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2013.10.003_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/039463200802100128","article-title":"Dilated cardiomyopathy due to thrombotic microangiopathy as the only manifestation of antiphospholipid syndrome: a case report","volume":"21","author":"Vaccaro","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.rdc.2013.10.003_bib44","first-page":"1259","article-title":"Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death","volume":"22","author":"Abu-Shakra","year":"1995","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.003_bib45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","article-title":"Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.003_bib46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1378\/chest.69.5.700","article-title":"Coronary arteritis in systemic lupus erythematosus","volume":"69","author":"Heibel","year":"1976","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2013.10.003_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-8703(72)90133-0","article-title":"Coronary arteritis, occlusion, and myocardial infarction due to lupus erythematosus","volume":"83","author":"Bonfiglio","year":"1972","journal-title":"Am Heart J"},{"key":"10.1016\/j.rdc.2013.10.003_bib48","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.autrev.2012.03.002","article-title":"Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review","volume":"11","author":"Artenjak","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2013.10.003_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0961203307076697","article-title":"Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies","volume":"16","author":"Sherer","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2013.10.003_bib50","first-page":"696","article-title":"Myocardial infarct in a child with systemic lupus erythematosus","volume":"132","author":"Ishikawa","year":"1978","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.rdc.2013.10.003_bib51","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.rdc.2013.10.003_bib52","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0002-9343(87)90762-5","article-title":"Dyslipoproteinemia in systemic lupus erythematosus: effect of corticosteroids","volume":"83","author":"Ettinger","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis","volume":"96","author":"Petri","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/art.23352","article-title":"Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?","volume":"59","author":"Karp","year":"2008","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2013.10.003_bib56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.06.010","article-title":"Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus","volume":"121","author":"Salmon","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib57","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncpcardio0270","article-title":"Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease","volume":"2","author":"Haque","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2013.10.003_bib58","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1177\/0961203396005001051","article-title":"Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis","volume":"5","author":"Petri","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2013.10.003_bib59","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard.2010.136762","article-title":"Lupus Atherosclerosis Prevention Study (LAPS)","volume":"70","author":"Petri","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.003_bib60","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/hc0802.104291","article-title":"Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near- infrared spectroscopy","volume":"105","author":"Moreno","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.003_bib61","doi-asserted-by":"crossref","first-page":"R214","DOI":"10.1186\/ar3193","article-title":"Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus","volume":"12","author":"Anania","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2013.10.003_bib62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<93::AID-PATH696>3.0.CO;2-H","article-title":"Association of coronary plaque rupture and atherosclerotic inflammation","volume":"181","author":"Boyle","year":"1997","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.rdc.2013.10.003_bib63","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archinte.1924.00110300044002","article-title":"A\u00a0hitherto undescribed form of valvular and mural endocarditis","volume":"33","author":"Libman","year":"1924","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib64","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjmed.2007.01.024","article-title":"Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution","volume":"120","author":"Moyssakis","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib65","first-page":"224","article-title":"Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study","volume":"35","author":"Roldan","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.003_bib66","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0002-9343(88)80236-5","article-title":"Clinically significant valvular heart disease in systemic lupus erythematosus","volume":"85","author":"Straaton","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(75)90331-9","article-title":"Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement","volume":"59","author":"Paget","year":"1975","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2013.10.003_bib68","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/096120339600500306","article-title":"Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves","volume":"5","author":"Ziporen","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2013.10.003_bib69","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/CIRCULATIONAHA.110.987560","article-title":"Aortic valve replacement in the elderly: determinants of late outcome","volume":"124","author":"Ashikhmina","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.003_bib70","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/0961203313498797","article-title":"Transcatheter aortic valve replacement for advanced valvular disease in active SLE and APS","volume":"22","author":"Bert","year":"2013","journal-title":"Lupus"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:11:48Z","timestamp":1760181108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X13000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0889857X13000902"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2013.10.003","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Manifestations of Systemic Lupus Erythematosus","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2013.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}